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A model of cardiac contraction based on novel measurements of
tension development in human cardiomyocytes
Sander Land1∗ So-Jin Holohan2 Nicolas P. Smith3
Cristobal G. dos Remedios4 Jonathan C. Kentish2 Steven A. Niederer1
Abstract
Experimental data from human cardiac myocytes at body temperature is crucial for a quantitative
understanding of clinically relevant cardiac function and development of whole-organ computational
models. However, such experimental data is currently very limited. Specifically, important mea-
surements to characterize changes in tension development in human cardiomyocytes that occur with
perturbations in cell length are not available. To address this deficiency, in this study we present
an experimental data set collected from skinned human cardiac myocytes, including the passive and
viscoelastic properties of isolated myocytes, the steady-state force calcium relationship at different
sarcomere lengths, and changes in tension following a rapid increase or decrease in length, and af-
ter constant velocity shortening. This data set is, to our knowledge, the first characterization of
length and velocity-dependence of tension generation in human skinned cardiac myocytes at body
temperature.
We use this data to develop a computational model of contraction and passive viscoelasticity in
human myocytes. Our model includes troponin C kinetics, tropomyosin kinetics, a three-state cross-
bridge model that accounts for the distortion of crossbridges, and the cellular viscoelastic response.
Each component is parametrized using our experimental data collected in human cardiomyocytes at
body temperature. Furthermore we are able to confirm that properties of length-dependent activa-
tion at 37◦ C are similar to other species, with a shift in calcium sensitivity and increase in maximum
tension. We revise our model of tension generation in the skinned isolated myocyte to replicate re-
ported tension traces generated in intact muscle during isometric tension, to provide a model of
human tension generation for multi-scale simulations. This process requires changes to calcium
sensitivity, cooperativity, and crossbridge transition rates. We apply this model within multi-scale
simulations of biventricular cardiac function and further refine the parametrization within the whole
organ context, based on obtaining a healthy ejection fraction. This process reveals that crossbridge
cycling rates differ between skinned myocytes and intact myocytes.
Key words: Cardiac muscle, Force generation, Viscoelasticity, Human cardiomyocytes, Computa-
tional modelling
1 Introduction
Computational models of human cardiac function are increasingly used to study cardiac physiology in
health and disease [50, 2, 15, 3]. These complex multi-physics and multi-scale cardiac simulations combine
models that represent the distinct physiology of the material properties, cellular electrical activity and
cellular contraction. When constructing multi-scale models of human function, there are currently many
options for characterizing the cellular electrophysiology [19, 52] or material properties [66, 48]. Detailed
biophysical models of cardiac contraction do exist for other species [56, 8, 36] and have been used to great
effect in multi-scale computational models, particularly in the mouse [59, 40] and rat [51, 39]. These
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models have the advantage that they can be used to link changes in sub-cellular properties to whole
organ contractile performance, predicting key indicators of cardiac function from changes to individual
channels or proteins involved in calcium regulation and contractile dynamics. However, there remains
a deficit of human biophysical models of tension generation which can be embedded within models of
whole organ contraction. Currently whole organ frameworks typically rely on phenomenological models
of cellular function [30, 58] or models preferentially fitted to animal data [64].
A major reason for this disparity between human and animal models is the historically poor avail-
ability of contraction data from human isolated myocytes, trabeculae and muscle strips. Specifically,
although data for isometric twitch contractile function exists [53, 44] and has been used to parametrize
contraction models [64, 36], comprehensive data sets for human myocyte contractile function which
characterize length- and velocity-dependence of tension generation are not available. In addition, many
measurements across species are taken at lower temperatures, including measurements of human my-
ofibrils [54], which limits their application for explaining whole organ contractile function. Finally, the
assumption that rapid reactions can be approximated as being in steady-state that can be valid in the
faster contractile dynamics of rodent hearts may not be valid in the slower contractile dynamics in
humans. This limits the ability to simply re-parametrize a small animal model.
In this study we address these deficits by presenting a comprehensive new data set in human cardiac
myocytes at 37◦C, measuring the relation between force, calcium concentration and sarcomere length,
the response to fast changes in length, and the passive viscoelastic response of these cells. We then
use this data to develop a new model of human cardiac contraction, which is suitable for multi-scale
modelling, based on the hypothesis that our preparations in skinned cardiac myocytes have crossbridge
dynamics consistent with intact cells in whole organ function, and compare our predictions from skinned
myocyte data with literature data from intact myocytes and expected whole organ ejection. Finally, we
apply this model to quantify differences between skinned myocytes and cellular function in the heart.
2 Methods
Our experimental data includes measurements of passive elasticity, steady-state force calcium relation-
ships at different sarcomere length, and dynamic changes in tension generation during length perturba-
tions in isolated myocytes. Frozen samples of left ventricular myocardium from healthy unused donor
hearts were obtained from the Sydney Heart Bank in Australia. The experimental set up and procedures
were generally similar to those reported previously [23], except that the force measurements were made
at a solution temperature of 37◦ C rather than 15◦ C.
2.1 Solutions
Relaxing solution contained (mM) BES 100, K propionate 55, Na2 phosphocreatine 10, Na2H2ATP 6.21
(for MgATP2− = 5), MgCl2 6.24 (for Mg2+ = 1), dithiothreitol 2, EGTA 10, Pi 1.2, AEBSF 1, leupeptin
0.002 and E64 0.002; pH 7.1 at 37◦ C, ionic strength 0.20 mol/L. For pre-activating solution 9.85 mM of
the EGTA was replaced by HDTA, while for activating solutions 4 - 10 mM of the EGTA was replaced
by CaEGTA. Maxchelator software (http://maxchelator.stanford.edu/) was used to calculate Ca2+
concentrations under the different experimental conditions.
2.2 Cell preparation
Fragments of the samples were thawed and single cardiac myocytes and myocyte fragments were prepared
by careful glass homogenization of the tissue. The myocytes were permeabilised with 0.5% Triton X-
100 v/v (Sigma Aldrich) in relaxing solution for 30 min at room temperature. The homogenate was
centrifuged (4000 rpm, 4.5 min) and the myocyte pellet was washed three times in cold relaxing solution
(4◦ C) to thoroughly remove any traces of Triton X-100. The myocyte suspension was stored on ice
and used within 48 hours. The ends of a skinned single myocyte were glued at room temperature using
Silicon adhesive (Aqua-Sil, Den Braven) or UV-setting glue (OA63 adhesive and Opticure LED-200 UV
light source, Norland), between pins extending from a force transducer and a high-speed length controller
(403A and 315C-I, Aurora Scientific Inc., Ontario, Canada).
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2.3 Measurements of passive viscoelasticity
Passive viscoelasticity was first measured using a series of five 1s step stretches with the myocyte in
relaxing solution [23]. Resting sarcomere length (measured using Aurora HVSL.901A video analysis
software at 200 Hz) was set to 1.95–2.05 µm in relaxing solution. Clampex (pClamp, version 10.3,
Molecular Devices) was used to record data and control the motor and perfusion systems.
2.4 Measurements of steady-state force-calcium relationship and dynamic
response to fast stretches
After measurement of passive viscoelasticity, a fast perfusion system (SF-77B, Warner Instrument Corp)
was used to activate each myocyte in the following sequence: pre-activating solution for 4–5 s, activating
solution for 7 s, relaxing solution for 5 s (Figure 1). During steady Ca2+ activation the cell was released
by 10% of resting cell length (CL), then re-stretched 40 ms later, to help stabilize the sarcomeres. After
1–2 s, when force recovery from the release/restretch was complete, the cell was stretched by 0.5%, 1%,
or 2% of CL in 10 ms, and held there for 1s. This stretch was slower than we used previously (2 ms
[23]), but was done to minimize cellular damage, as the myocytes appear less robust at 37◦ C than at the
temperature of 15◦ C used previously. After selecting for data quality and noise levels, we have n = 5
traces where 0.5% and 2% stretch was applied, and n = 11 traces where a 1% stretch was applied, due to
more experiments being performed with 1% stretch protocol. The activation protocol was repeated for a
range of calcium concentrations. Any decline in isometric force development was measured and corrected
for using a reference activating solution (pCa 5.96 or 5.81) applied at intervals. The experiment was
terminated when isometric force had declined by more than 20% from the first activation; this usually
occurred after about 30 activations. When determining the force-calcium relation for SL = 1.8 µm, 2.0
µm or 2.2 µm, the SL was set with the myocyte in relaxing solution. Since 1.8 µm is below the slack
length of the sarcomere (∼1.9 µm), to set the SL to be 1.8 µm in the activated cell, the relation between
SL and cell length was first determined in the relaxed myocyte using a series of length steps over the
SL range 1.9 to 2.2 µm, then the cell was shortened to the length that would allow the sarcomeres to
shorten during activation to SL = 1.8 µm, as estimated from extrapolation of the SL-cell length relation.
2.5 Measurements of dynamic response to constant velocity shortening
Methods for this protocol were identical to those for the dynamic response to fast stretches, except for
the change in cell length applied. During steady Ca2+ activation the cell was shortened by 7–11% of
resting cell length (CL) starting from a sarcomere length of 2.3 µm, with a ramp of duration 100–300
ms, that is, with a velocity of 0.54 to 2.53 µm/s.
3 Results
We develop our multi-scale model of cardiac contraction by sequentially adding model complexity and
experimental data, starting with the passive force, then steady-state activation, velocity-dependent dy-
namics, isometric twitch kinetics, and finally whole-organ contraction.
Our experimental results and modelling are described in the following sections. Firstly, in section
3.1 we develop a model of the passive viscoelastic response of the human cardiac myocytes. This model
is independent of the fitting of the active tension model in subsequent sections, and is kept constant
throughout later modelling. Section 3.2 describes the model of active contraction. In section 3.3 we fit this
active tension model to measurements of the steady-state force-calcium relationship at different sarcomere
lengths. Next, in section 3.4 we extend this model to include the response to dynamic length- and velocity
changes, keeping parameters fitted in the steady-state and constraining additional parameters. We adjust
the resulting model of a skinned myocyte to represent intact muscle function, by fitting the model to
measurements of isometric twitch data from the literature in section 3.5. Finally, in section 3.6 we create
a multi-scale model of biventricular cardiac mechanics, and use it to further refine our cellular model of
an intact myocyte, for optimal use in a whole organ model.
3
Figure 1: Experimental protocol and example measurement trace. Force is shown in the top
panel, with the change in cell length in the bottom panel. After activation to steady-state force, and a
brief release/re-stretch protocol to help stabilize the sarcomeres, dynamic function is measured using a
1% increase and decrease in cell length, before applying a relaxing solution.
3.1 Passive viscoelastic model
Myocytes, in addition to sharing elastic properties with other types of cells, have a particular viscous
response, thought to derive primarily from the molecule titin, which is part of the contractile apparatus
[43]. We assume the passive response is independent of other experimental data on active tension
presented in this manuscript, due to the presence of a relaxing solution, which suppresses active tension
generation to negligible levels.
The data set used to constrain the parameters for the model of passive viscoelasticity includes mea-
surements of sarcomere length, force, and cell area for n = 7 cells, and five different step sizes per cell,
stretching the cell by 2–10%. Maximal tension development shows high variability, reaching 3.2 ± 1.45
kPa at the end of the decay of the biggest step. We attribute this in part to variability and uncertainty
in the cell area as it was measured prior to stretch and not recorded dynamically during experiments.
Another potential source of variability is the variable amount of endomysial collagen in these prepara-
tions, which may contribute to cell stiffness. To compensate for this variability, experimental data was
normalized to have identical force at the end of the last stretch (equal to the mean over all experimental
traces).
Figure 2 shows the mean change in length in the upper panel and the mean and individual normalized
force measurement in the lower panel. There is a clear viscous component to the force as indicated by the
large spikes and subsequent decay after a quick stretch. This viscous component represents 44 ± 5% of
total passive force, and 75% of this force decays within 92± 24 ms. On shortening, the viscous response
is significantly smaller, potentially due to a much faster decay rate and recovery during the duration of
the shortening step.
The passive response was modelled using a three-parameter model similar to a standard linear solid,
consisting of a dashpot and spring in series, in parallel with another spring (see Figure 2C). This model
was chosen for its simplicity and its ability to capture the passive and viscoelastic response shown in our
experimental data. To reproduce the typical exponential force-length relationship seen in both our data,
and previous experiments in isolated cells and cardiac tissue [23, 66, 31], the parallel spring F1 has an
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Figure 2: Passive tension data and model fit. Panel (A) shows the mean sarcomere length mea-
surement. Panel (B) shows passive tension data and model fit. Grey traces show n = 7 individual
data traces, normalized to match the mean value at the black ‘X’. The blue trace indicates the mean
passive tension, and the red trace is our model fit. Panel (C) shows the model we use for the viscoelastic
response, which is similar to a standard linear solid. F1 is a spring with an exponential stress-strain
relationship, F2 is a linear spring, and Fd a dashpot. The active contractile element TA is introduced in
later sections, and has zero stiffness in the model fitting to passive tension data.
exponential behaviour. However, to both limit the number of parameters, as well as ensure an analytical
solution to the series force constraint (Equation 7 below), we use a linear relationship for the spring F2
in series with the dashpot. The dashpot element has separate parameters for shortening and lengthening
to accommodate the difference in viscous forces observed.
These considerations result in the following set of equations for our passive tension model:
λ = SL/SL0 (extension ratio, as in e.g. [37]) (1)
C = λ− 1 (strain) (2)
F1 = a(e
bC − 1) (parallel elastic element) (3)
F2 = akCs (series elastic element) (4)
Fd =
{
aηl
dCd
dt
dCd
dt > 0
aηs
dCd
dt
dCd
dt < 0
(viscous dashpot element) (5)
Cs + Cd = C (series strain constraint) (6)
F2 = Fd (series force constraint) (7)
Ftot = F1 + F2 = F1 + Fd (total force) (8)
Note that the parameter a is included in all forces, such that rescaling total passive force can be accom-
plished by a single parameter change. The resting sarcomere length SL0 is estimated using the average
of the early part of the experimental SL trace for each cell, before the first stretch. We first fit the serial
spring’s stiffness as a · k = 14 to match the peaks of the viscous response. Next, we fit the remaining
model parameters a, b, ηl, ηs to the mean normalized experimental force of our cellular data, minimizing
S =
∫ ‖Ftot − Fexp‖2 where Fexp is the experimental mean force. Parameters were rounded to a num-
ber of significant digits reflecting the sensitivity of parameters to the cost function, by rounding each
parameter in turn, while keeping the minimization criterion S within 0.2% of the optimal value.
Final parameters are a = 2.1 kPa, b = 9.1, k = 7, ηl = 200/ms, ηs = 20/ms, reflecting relatively low
sensitivity to the viscous forces, and higher sensitivity of the passive tension parameters a, b. Figure 2
shows experimental data and model fit.
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3.2 Active tension model
In this section we develop our active tension model and fit it to our human cardiomyocytes data on
steady-state force development, length dependence of this force development, and dynamic changes in
tension due to fast changes in cell length.
The force generating apparatus of the cell consists primarily of two types of filaments, thick filaments
and thin filaments. Thin filaments are composed of actin, tropomyosin, and troponins, including troponin
C and troponin I. Thick filaments are made up of myosin crossbridges [18, 60, 61, 5, 46]. Active tension
is generated by myosin crossbridges attaching to binding sites on actin on the thin filament, and then
performing a powerstroke. Crossbridges consist of a head region which rotates during a powerstroke, and
a tail region (the neck region of the myosin molecule) which is distorted. The restoring forces on the
spring-like tail are responsible for force generation. As the filaments slide past each other, the distortion
of the crossbridge tail which was generated by the powerstroke is reduced, generating less force. By
detaching, returning to their resting length, and re-attaching to a new binding site and once again
performing a powerstroke, crossbridges restore their maximal force generating ability. In the resting
state, tropomyosin, which winds helically around actin on the thin filament, sterically blocks the binding
sites for myosin on actin. It is held in this ‘blocking’ position by troponin I, another thin filament protein.
When the cell is electrically activated, the calcium concentration rises. Calcium ions (Ca2+) from the
cytosol bind to the regulatory binding site on troponin C. This causes troponin C to open a binding
pocket for troponin I, causing troponin I to preferentially move away from holding tropomyosin in the
‘blocked’ position, allowing crossbridges to bind and generate tension.
Our goal is to develop a model of active contraction in the human heart with a level of complexity that
reflects the available experimental data, and which can be efficiently used in multi-scale cardiac mechanics
models. Therefore we choose a strategy based on a low-dimensional set of ordinary differential equations,
and avoid techniques based on partial differential equations [65] or very high-dimensional ODE models
[36, 8].
The model definition in the following sections is based on the different contractile proteins. Firstly, we
describe our model for thin filament kinetics, involving troponin and tropomyosin. Secondly, we develop
a model of the crossbridge cycle, including distortion-decay kinetics related to changes in length of the
cell. Finally, we introduce a model of the length-dependence of tension in cardiac cells.
3.2.1 Thin filament kinetics
Thin filament kinetics are described by the interactions of calcium ions, troponin C, troponin I and
tropomyosin to regulate availability of myosin binding sites on actin. Activation of the thin filaments
shows highly cooperative behaviour, with small changes in intracellular calcium leading to potentially
high changes in force. The main biophysical reason for this behaviour relates to the end-to-end overlap
of tropomyosin molecules. Explicitly capturing these interactions between neighbouring molecules tends
to require complex models [36]. We choose a relatively simple and phenomenological representation of
cooperative activation, as it is better suited for applications in multiscale modelling.
With respect to troponin, our new active contraction model inherits troponin C dynamics and param-
eters other than calcium sensitivity from previous murine work [37], as these proteins are highly conserved
across species [41], and we do not have new experimental data to constrain most of the parameters:
dCaTRPN
dt
= kTRPN
((
[Ca2+]i
[Ca2+]T50
)nTRPN
(1− CaTRPN)− CaTRPN
)
(9)
Where CaTRPN represents the fraction of troponin C units with calcium bound to its regulatory
binding site. The parameter kTRPN = 0.1/ms represents the unbinding rate, nTRPN = 2 the cooperativity
of the calcium-troponin C binding rate. The parameter [Ca2+]T50, which describes the half-activation
point, is not consistent between species. This parameter needs to be fit depending on the calcium
transient used to drive the model, and will be fit to experimental data below. The troponin concentration
CaTRPN drives the unblocking of tropomyosin, as represented by the fraction of blocked myosin binding
sites on actin, denoted by B:
dB
dt
= kb · CaTRPN−nTm/2 · U − ku · CaTRPNnTm/2 ·B (10)
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Figure 3: Overview of the active tension model. States included the ‘blocked’ state ‘B’, the unbound
crossbridge state ‘U’, the pre-powerstroke state ‘W’ and the force-generating state ‘S’. Both the states
‘W’ and ‘S’ have an additional state ζw, ζs keeping track of the mean distortion of crossbridges in this
state. Calcium binding to troponin C (Trpn) drives the transition between states ‘B’ and ‘U’.
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Where U is the fraction of unblocked myosin binding sites without crossbridges bound. The equation
for dBdt is similar to those used in previous work [37, 56], giving a cooperative Hill curve with coefficient
nTm as the steady-state relation between CaTRPN and the fraction of unblocked binding sites 1 − B.
For numerical stability, the term CaTRPN−nTm/2 is limited to a maximum value of 100.
3.2.2 Crossbridge model
Crossbridge binding and force generation are modelled using a three-state crossbridge cycle with unbound
(U), pre-powerstroke (W ) and post-powerstroke (S) states, and a distortion-decay model which tracks
the average distortion of crossbridges in the W and S states.
U = (1−B)− S −W (11)
dW
dt
= kuwU − kwuW − kwsW − γwuW (12)
dS
dt
= kwsW − ksuS − γsuS (13)
Here γwu, γsu are distortion-dependent unbinding rates of crossbridges in the W and S state, given
by a distortion-decay model [14, 55]. We use a relatively simple distortion-decay model, inspired by the
work of Ford et al. [14], Razumova et al [55], and Rice et al. [56]. These models assume crossbridges are
linearly elastic, and tension is generated by both distortion induced by the powerstroke, and distortion
induced by imposed changes in cell length. This induced distortion then decays over time as crossbridges
unbind and reattach in an undeformed state. In addition, the distorted crossbridges are more likely to
unbind. Although more distortion-dependent binding rates have been suggested [56], we only use an
increase in crossbridge unbinding rates due to distortion. This captures the most salient features of our
experimental data, notably the ‘dip’ in tension after a stretch, with a limited number of parameters.
We also avoid exponential functions in these dependencies, as they can lead to increased stiffness of the
resulting equations, and potential instability when applied in a multiscale modelling setting.
Our distortion-decay model is given by:
dζw
dt
= Aw
dλ
dt
− cwζw (14)
dζs
dt
= As
dλ
dt
− csζs (15)
γwu = γw|ζw| (16)
γsu =
 γs(−ζs − 1) if ζs + 1 < 0γsζs if ζs + 1 > 1
0 otherwise (if ζs + 1 ∈ [0, 1])
(17)
Where Aw and As relate to the magnitude of the instantaneous response to distortion, and cw and
cs to the decay rate of distortion. All variables with the subscript ‘w’ relate to the pre-powerstroke state
W , and variables with the subscript ‘s’ relate to the post-powerstroke state S. The variable λ indicates
the cell length relative to the resting length [37].
Like previous models, we assume that crossbridges bind with zero distortion (not generating any
tension) in the pre-powerstroke state. Furthermore, when making a powerstroke (transition from W
to S), crossbridges do not retain their distortion, but end up with exactly the distortion induced by
the powerstroke. This greatly simplifies the equations, without significantly impacting model results, as
distortion in the W state quickly decays. Unlike some previous models [55], the distortion ζw, ζs in our
model are given relative to the powerstroke distortion, with ζw = 0 indicating no distortion, and ζs = 0
indicating no additional distortion to that given by the powerstroke.
In the absence of changes in cell length, we have ζw = ζs = 0, and the total active tension is given
by:
Ta = number of crossbridges× crossbridge stiffness× powerstroke distortion× S (18)
When considering the distortion in both the W and S states, the total tension is proportional to:
Ta ∼ ((ζs + 1)S + ζwW ) (19)
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The distortion-dependent unbinding term has already been incorporated in the equations for dWdt
and dSdt (Eq. 12,13). In the pre-powerstroke state, the distortion-dependent unbinding rate γwu is taken
as proportional to distortion ζw. For the post-powerstroke state we assume the absence of significant
distortion-dependent unbinding for any strain between the normal pre-powerstroke and post-powerstroke
states, i.e. for ζs + 1 ∈ [0, 1]. For ζs outside this range, distortion-dependent unbinding scales as the
absolute distance to this range, as represented by Equation 17. This is based on both the unbinding func-
tions proposed in Huxley-type models [25, 65], and the observation that recovery after a 2% shortening
step is monotonic (Figure 5), while including significant distortion-dependent unbinding for ζs+1 ∈ [0, 1]
results in non-monotonic recovery,
In a cycle of reactions, such as in our crossbridge model, it is typically easier to parameterize based
on the steady-state occupation of states, and an overall rate of cycling, which governs both forward
and backward rates. The steady-state occupation can be more easily constrained using a prior or fixed
value, as it is less species-dependent, while the overall rate of cycling governs the kinetics of tension
development, and is likely to vary significantly between species.
Thus, we introduce the following definitions:
rs = steady-state duty ratio = steady-state
S
U +W + S
(20)
rw = steady-state ratio between pre-powerstroke and non-strongly bound = steady-state
W
U +W
(21)
TRPN50 = value of CaTRPN where B = 0.5 in steady-state (22)
The introduction of these variables aids in parametrization of the model as it is easier to provide
a good initial estimate for rs, rw and TRPN50, compared to directly estimating kb, ksu and kwu. We
fix the duty ratio at rs = 0.25 as in previous modelling, and consistent with experimental values for
a myosin dimer [8, 36]. Secondly, we have found both TRPN50 and rw to be not well constrained by
experimental data, with a range of values giving similar model fits. Thus, we keep TRPN50 = 0.35 at
the value introduced in previous work [37], which results in a peak isometric twitch tension between 1/3
and 1/2 of maximal tension, leaving potential for a strong length-dependent response. We fix rw = 0.5
in the middle of the range of [0.25, 0.75] we have found to fit experimental data. The derived parameters
used in the model equations are given by:
kwu = kuw(1/rw − 1)− kws (23)
ksu = kwsrw(1/rs − 1) (24)
kb = kuCaTRPN
nTm/(1− rs − (1− rs)rw) (25)
In addition, the magnitude of instantaneous distortion in the W and S states are assumed to be equal
as they reflect the distortion induced by relative movement of the filaments.
As = Aw = Aeff · rs/((1− rs)rw + rs) (26)
The assumption of As = Aw reduces the number of parameters to be estimated by one. The rescaling
using Aeff more accurately reflects the instantaneous stiffness due to distortion, i.e. the size of the peaks
in tension after a quick stretch is reflected by Aeff alone, independent of the choice of rs, rw.
Next, we assume distortion decay rates to be proportional to steady-state crossbridge cycling rates:
cw = φ · kuw · U/W = φ · kuw · ((1− rs)(1− rw))/((1− rs)rw) (27)
cs = φ · kws ·W/S = φ · kws · ((1− rs)rw)/rs (28)
This definition effectively eliminates a parameter by reducing two parameters (cw, cs) to one (φ). Specif-
ically, as we assume new crossbridges enter a state with zero distortion, and unbind with average dis-
tortion, we expect the distortion decay rates are proportional to the relative increase in the state (e.g.
cs ∼ kwsW/S, as kwsW is the increase in S from the W to S transition). This approach is described in
more detail in previous work using distortion-decay models [55, 56].
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3.2.3 Length-dependence of tension
Another key aspect of tension generation in the heart is the increase in generated force with an increase
in cell length. At the organ level, this phenomenon gives rise to the ‘Frank-Starling’ effect, where an
increase in end-diastolic volume leads to an increase in the volume of blood ejected, ensuring a balance
of flow in and out of the heart. The molecular mechanisms underlying these effects have not been fully
resolved [10].
We use a phenomenological model to represent the cellular effects, which are characterized by a shift
in the sensitivity to intracellular calcium, and an increase in maximum generated tension with length
[1, 16, 17, 21]. These effects are each represented by a single parameter, as in previous work:
[Ca2+]T50 = [Ca
2+]refT50 + β1 (min(λ, 1.2)− 1) (29)
h(λ) = max(0, h′(min(λ, 1.2)) (30)
h′(λ) = 1 + β0(λ+ min(λ, 0.87)− 1.87) (31)
The parameter β0 represents the change in maximal tension, based on changes in filament overlap [56, 37].
The parameter β1 captures the change in calcium sensitivity [37].
Total active tension of the complete model is given by:
Ta = h(λ)
Tref
rs
((ζs + 1)S + ζwW ) (32)
Where Tref is the maximal active tension at resting length. This equation results in active tension being
equal to Tref when S = rs, as is expected at maximal calcium, when B = 0.
3.3 Steady-state force-pCa and length-dependent response
Measurements of the steady-state force-calcium relation for n = 5 cells were acquired at sarcomere
length 1.8, 2.0, and 2.2 µm. Our measurements show the typical cooperative relationship between force
and calcium concentration, with maximum force increasing with length, and the mid-point of activation
shifting towards lower calcium levels at higher sarcomere length. Also consistent with previous work, we
do not observe a change in cooperativity at this range of sarcomere lengths [28].
We use these measurements of the steady-state force-calcium relation of human cardiac myocytes to
fit both cooperative activation and the length-dependent changes in both maximum force and calcium
sensitivity in our model. Specifically, we fit calcium sensitivity [Ca2+]refT50, Hill coefficient nH , and
length-dependent parameters β0, β1 to the experimental dataset, using the Nelder-Mead algorithm for
multidimensional unconstrained nonlinear minimization in MATLAB. Experimental data (Figure 4)
shows a degree of variability between cells, both in maximal developed tension and half-activation point.
Tension is calculated as measured force divided by an estimate of cross-sectional area, therefore cell
morphology and errors in cell area measurements may be the underlying cause of variations in maximum
observed tension Tref. The reason for variability in calcium sensitivity [Ca
2+]refT50 is less clear, but may be
related to differences in regulation of calcium dynamics due to residual phosphorylation, as a result of
medication used in the process of keeping donor hearts viable. To compensate for the high variability of
experimental data, we allow [Ca2+]refT50, Tref to vary for each cell, to more accurately estimate the other
parameters.
Best fit model parameters are given by nTm = 2.2, β1 = −2.4, β0 = 2.3 with the means and standard
deviations of the individually fitted parameters as Tref = 40.5± 14.9 kPa and [Ca2+]refT50 = 2.5± 0.66 µM.
These model results indicate a clear length-dependent maximum increase in force (β0 > 0), with shift
to higher calcium sensitivity with increased cell length (β1 < 0) . Figure 4 shows experimental data and
resulting model fits.
3.4 Velocity-dependent response
We have performed two sets of experiments relating to the acute tension response after changes in
length, also known as the velocity dependence of tension. The data (Figure 5A-C) shows the response
of a myocyte to a quick stretch. Force increases instantly due to distortion of crossbridges, then rapidly
decays and drops below the eventual steady-state tension at the increased length as distorted crossbridges
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Figure 4: Fitting cooperative activation of the model. The ‘x’ indicate experimental data points,
with lines indicating fits to individual cells. The black line indicates the resulting mean fit.
Figure 5: Fitting velocity dependence. The three panels (A1,A2,A3) show quick stretch experiments
with 0.5% stretch, 1% stretch and 2% applied in 10ms from left to right. Grey traces are experimental
data, averaging to the blue trace. Best model fit is given by the smooth red trace. Panel (B) shows
constant velocity shortening experiments and results of our skinned and intact myocyte models. Raw
data can be found in Appendix D. The expected force development to produce sufficient ejection in
the heart is approximately 70% at constant shortening of 20% in 150-200 ms, well outside the function
observed in skinned myocytes.
detach, before recovering to a higher steady-state level of tension due to length-dependent effects [14].
Following shortening, we do not observe the biphasic force response seen after a rapid stretch. In contrast,
the induced distortion causes force to decrease instantly, before recovering in a smooth, monotonically
increasing manner, consistent with previous experiments [14]. In addition, we have data on constant
velocity shortening, where cell length decreases by 7–11% over 100–300 ms. We combine these two data
sets to select a set of model parameters kws, kuw, φ, γs, γw which fits both types of experimental data
well. Details of the cost functions and fitting are given in Appendix C.1. Results are shown in Figure 5.
3.5 Isometric twitch response in intact muscle
The model developed in the previous sections is constrained from data measured in skinned isolated
myocytes. Skinned myocytes are known to differ from intact muscle. In particular, calcium sensitivity,
cooperativity, and maximal active tension can all be significantly different [28, 5]. Note that our skinned
cells have a calcium sensitivity of ∼3 µM, while a calcium transient in an intact human myocyte (Figure
6A) has a peak calcium level of 0.6 µM. We assume intact muscle shares other properties with skinned
myocytes, and differs mainly in these three parameters: calcium sensitivity [Ca2+]refT50, Hill coefficient of
cooperative activation nTm, and maximal tension Tref.
In this section we fit the model to isometric twitch data to capture in vivo function and make
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the model suitable for use in a multiscale cardiac mechanics modelling framework. Our experimental
data is limited to skinned myocytes, as the freezing process for unused donor hearts compromises the
cell membrane. Thus, we rely on published literature data to guide the parametrization of the model
to represent intact muscle function. Combined force, length and calcium measurements from intact
trabeculae have not been reported. Here we integrate observations of calcium transients and tension
transients from different sources, to estimate the differences in parameters between skinned myocytes
and intact tissue preparations
The calcium transient we use as input is based on work by Coppini et al. [9], which is shown in
Figure 6. We use isometric twitch measurements from isolated left ventricular muscle strips [44, 53] at
body temperature, from which we derive our target ranges for a time to peak tension (TPT) of 147–172
ms, a time to 50% relaxation (RT50) of 109–125 ms and a time to 95% relaxation (RT95) of 291–377
ms. These metrics along with criteria for maximal and minimal tension development are combined into
a cost function and solved to result in optimized model parameters [Ca2+]refT50, nTm, ku, as described in
more detail in Appendix C.2. Resulting metrics for activation and relaxation with the optimal parameter
set are a time to peak of 237 ms, relaxation times RT50=190 ms, RT95=447 ms, a peak tension of 34.8
kPa and a minimum tension of 0.8 kPa during 1 Hz pacing. The tension development and relaxation
rates are well outside the measured ranges for isometric twitch, while the maximal tension is below that
typically required to achieve a healthy ejection fraction in multi-scale simulations.
From Figure 5A we can also see that crossbridge kinetics are slow in skinned myocytes, with recovery
of tension taking several hundreds of milliseconds after 2% shortening, and Figure 5B shows that tension
development at the shortening rate observed during the fast ejection phase is expected to be well below
the range compatible with a healthy ejection fraction. On the basis of these observations, we introduce
additional model parameters in fitting: factor µ, which scales the weak-to-strong crossbridge transition
rate kws, and ν, which scales the unbound-to-weak transition rate kuw. Note that this will also affect
recovery from distortion, c.f. Equation 28. We add ν, µ ∈ [1, 12] to our parameter sweep and keep other
parameter ranges.
Re-running the optimization with these additional parameters results in a crossbridge rate scaling
factor of µ = 3, resulting in kws = 0.012 ms, or approximately 1/8 of the corresponding rate-limiting
kinetic used in mouse modelling [37], which is consistent with the difference in heart rates between mouse
and human. Other parameters fitted are: nTm = 5, also consistent with previous modelling in intact
mouse muscle, as well as with experimental data in other species [28, 42, 12]; [Ca2+]refT50 = 0.805 µM,
consistent with the magnitude of the calcium transient, and tropomyosin kinetics ku = 1/ms at the
upper bound of our parameter sweep range. Further increasing ku does not significantly improve the fit,
indicating the current value is near steady-state.
The parameter sweep indicated that the parameter ν, which scales the unbound-to-weak transition
rate kuw, could not be constrained based on twitch kinetics. Values of ν ∈ [4, 12] all result in insignificant
differences with dt ∈ [7, 9], with no clear pattern of higher or lower ν consistently giving better fits. The
next section describes the use of whole-organ simulations to determine this final parameter, resulting in
our choice of ν = 7.
Resulting metrics for activation and relaxation are a time to peak of 175 ms, relaxation times
RT50=121 ms, RT95=281 ms, a peak tension of 51 kPa and a minimum tension of 0.078 kPa during
1 Hz pacing. The resulting twitch transients at different cell strains are shown in Figure 6.
3.6 Multi-scale model
In this section we use our newly-developed single cell model of human active contraction to drive a
three-dimensional finite element simulation of the heart. For use in a multi-scale context, we apply the
model of active tension in an intact cell as parametrized in the previous section, and define the total
tension of the cell model as:
Ttot = Ta + Fd = Ta + F2 (33)
That is, the viscoelastic response Fd is included in the cell model. The response Fd includes titin
and the effects of any residual endomysial collagen on the cells [23], but does not include the effects
of thick collagen bundles which limit the operating range of the heart to a maximal sarcomere length
of 2.35 µm[22], blood vessels, fibroblasts and other components of the myocardium. The constitutive
law represents all of these elements in a lumped description of the passive response of myocardium.
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Figure 6: Results for isometric twitch tension. The left panel shows the human calcium transient
used, provided by Coppini et al. The right panel shows the isometric twitch tension produced by our
model at resting length (thicker yellow line, λ = 1) and the length-dependent response at different
extension ratios.
As collagen present in the heart also adds to viscosity, the term Fd may underestimate total viscosity.
However, the viscous component of the model is dominated by the velocity dependence of tension, and
passive viscous component has very little effect on ejection fraction. The passive elastic response F1
(Equation 3) would typically be part of the constitutive law used, and should therefore not be included
in the cell model when used in a multiscale context.
The minimal implementation of the passive cell model (Equations 1–8) in this context is given by:
Tp = Fd = F2 = akCs (34)
Cs = (λ− 1)− Cd (35)
dCd
dt
= kCs/η (36)
η =
{
ηl Cs > 0
ηs Cs ≤ 0 (37)
Where the extension ratio λ is calculated from the fibre strain ‖Ff‖, where F is the deformation gradient
and f a unit vector in the fibre direction. A rule-based fibre direction was used, ranging from −60◦ at
the epicardium to +80◦ at the endocardium.
Three anonymised CT data sets were obtained from patients at St Thomas’ Hospital in London for
diagnostic purposes, but who were all found to have healthy heart function. CT images were ECG gated
for the R wave, giving the heart anatomy at end diastole. Each data set was segmented using the Philips
heart atlas based segmentation tool [13]. We use the meshing tool developed by Lamata et al. [32, 33]
to fit a cubic order finite element mesh to each segmented data set. Figure 7C shows the resulting finite
element meshes. To simulate biventricular cardiac function, we use our multi-scale cardiac mechanics
framework [34, 38], which has recently been verified [35].
The constitutive law of Guccione et al. was used to represent the material [20]:
W =
C1
2
(eQ − 1) (38)
Q =C2E
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31) (39)
Where W is the strain energy function and Eij are components of the Green-Lagrange strain tensor E
in a fibre-based coordinate system [35]. We use parameters C2 = 8, C3 = 3, C4 = 4 based on Nasopoulou
et al. [48] and C1 = 1 kPa to match end-diastolic volume. Meshes were ‘deflated’ to the reference
configuration using the backward displacement method [6]. Simulations were initiated by inflating the
reference configuration back to end-diastolic pressure. Left-ventricular end-diastolic pressure was set
to 1 kPa (7.5 mmHg). Active contraction was driven by a prescribed calcium transient, as shown in
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Figure 6, which was applied homogeneously throughout the geometry. During isovolumetric contraction,
volume in the respective ventricle was held constant by solving dVdt = 0 as a constraint within the
system of mechanics equations. Aortic pressure at start of ejection was set to pa = 9 kPa (67.5 mmHg).
When the left ventricular pressure reaches this point, ejection is started. Hemodynamics during ejection
were simulated using a standard three-element windkessel model, with left-ventricular parameters R =
0.852 mmHg s/ml, C = 2.73 ml/mmHg, Z = 0.035 mmHg s/ml based on data from from Murgo et al [45].
When during the solution process we notice a reversal in flow direction (dVdt < 0), the ejection phase ends,
and the isovolumetric relaxation phase of the solver is started. This phase continues until the pressure
reaches 0.1 kPa, at which point the model moves into diastole. A simple diastole model is used, which
serves to return the ventricles to end-diastolic pressure, given by dpdt = 0.01(p−EDP ). Right-ventricular
end-diastolic pressure was set to 1/3 of left ventricular pressure [26], and windkessel parameters were
set in accordance with an approximate 1 : 3 pressure difference, i.e. Crv = 3C,Zrv = Z/3, Rrv = R/3,
pa,rv = 3 kPa. Right ventricular diastolic filling was started at the same time as left ventricular diastolic
filling.
3.6.1 Whole organ simulations
To confirm changes between skinned and intact myocytes, we also perform whole organ simulations
µ = ν = 1. This results in ejection fractions of 20–25%, confirming the need to increase crossbridge
cycling rates. We test the optimal parameter set for isometric twitches for µ = 3 and ν between 1
and 12. Ejection fraction for each case is shown in Figure 7A, and shows a steeply increasing ejection
fraction until approximately ν = 7. Based on these results, we choose ν = 7, or kuw = 0.182 and
[Ca2+]refT50 = 0.805 µM. Figure 7B shows the pressure-volume loops of the final models representing
intact and skinned myocytes, with a clear difference in ejection and pressure development.
4 Discussion
In this manuscript we presented a comprehensive data set characterizing the passive tension and active
contractile properties of skinned human cardiac myocytes at body temperature, and used it to develop
a novel multi-scale computational model of the human heart.
The viscoelastic properties of cardiac cells are complex and involve folding and unfolding of titin [43],
with a contribution from the deformation of the cell membrane and cytoskeleton. However, we found that
an efficient single ODE model, similar to that of a standard linear solid, fits our data on passive tension of
cardiac myocytes, and has only five parameters. For active tension, we used a framework for troponin C
kinetics from previous modelling work, but separated tropomyosin and crossbridge kinetics into separate
equations. This allowed us to introduce a three-state crossbridge model, with a distortion-decay model
for the velocity-dependence of cardiac muscle.
The choices made in the final modelling framework give some implicit mechanistic insights. A major
motivation for introducing these extensions was the observation that the fading memory model [24] used
in some of our previous work [49, 37] did not accurately predict the response to shortening observed in our
experimental data. Specifically, the model gives a mirrored response to shortening versus lengthening,
and can not reproduce the monotonic recovery observed after shortening (Figure 5). This inspired
the development of a new model, extending the framework of Ford et al. [14], which captures the
asymmetric response to fast shortening and stretch. However, as crossbridge transition rates affect
the tension response to changes in cell length, the model parameters are less independent of other
equations than in the fading memory model. Separating tropomyosin and crossbridge kinetics fits with
this modelling approach, as it allows adding distortion-dependent unbinding rates (as reflected by γs, γw)
to crossbridge states, rather than distortion influencing tropomyosin kinetics directly. In addition, a two-
state crossbridge model did not capture distortion-decay kinetics accurately, while a three-state model
captures a fast component (due to weakly attached crossbridges) and a slower component (due to strongly
attached crossbridges) in tension recovery.
Fitting the steady-state force-calcium relationship at different sarcomere lengths revealed a relatively
low Hill coefficient in skinned myocyte data, as has been observed previously in skinned cells [5]. As
expected from previous work, we found skinned cell data was not compatible with measurements of
isometric twitch measurements. Specifically, calcium sensitivity in skinned cells predicts a half-activation
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Figure 7: Ejection fraction and pressure-volume loops. Panel (A) shows the change in ejection
fraction as a function of the unbound-to-weak crossbridge binding rate for each of our three patient cases,
showing stronger constraints (kuw > 0.18) than those found in isometric twitch fitting (kuw > 0.078), as
well as small differences in ejection fraction between the three cases. Panel(B) shows pressure-volume
relations for the original skinned model, and adjustment to crossbridge cycling rates using inferred
parameters based on isometric twitch tension and ejection fraction. Panel(C) shows our three patient-
specific meshes derived from CT scans, at their end-diastolic configuration.
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value of approximately 3 µM, which results in near-zero isometric twitch tension based on calcium data
measurements from Coppini et al., which have a peak value below 1 µM [9]. Thus, fitting isometric twitch
data required differences in cooperativity and calcium sensitivity. Although direct measurements of the
force-calcium response in intact cells would have helped to constrain these differences, the source of our
experimental data consists of snap-frozen tissue, in which an unknown proportion of the myocytes will
have been unavoidably permeabilized. Compared to experimental data, the RT50 values predicted by
the model are at the higher end of experimental data, and RT95 values are at the lower end, similar to
previous isometric twitch fitting in human models [36]. It remains to be seen if this difference is due to the
limited measurement data available, or is a particular feature of human cardiac myocytes. Tropomyosin
kinetics were best fit with a rate constant near steady-state, which suggests that tension development in
humans is rate-limited by crossbridge kinetics, consistent with recent consensus on rate-limiting kinetics
in cardiac tension generation [61].
A limitation of skinned myocytes which, to our knowledge, has not previously been recognized, is the
slower crossbridge kinetics. Specifically, modelling predicts that crossbridge cycling rates are higher in
intact myocytes compared to skinned myocytes at body temperature. As a result, in skinned myocytes
recovery from shortening-induced distortion of crossbridges happens on a time scale of around 1 second
which is too slow to allow for a healthy ejection fraction. Increasing the weak-to-strong crossbridge
cycling rate produced a model consistent with isometric twitch data. The unbound-to- weak transition
rate could not be exactly determined, but a more specific lower bound to this parameter was found by
using whole organ simulations, and the final intact cell model produced a healthy ejection fraction. The
weak-to-strong transition rate is estimated at approximately three times higher in intact compared to
skinned myocytes based on twitch kinetics, and the unbound-to-weak transition rate at at least seven
times higher based on a combination of isometric twitch results and ejection fraction. The resulting
crossbridge cycling rates are rsksu = 6/s in the skinned model and µ = 3 times higher (18/s) in the
intact model. The cycling rate in skinned cells in the model is approximately twice that of an estimate
derived from ATPase measurements at lower temperature in human skinned muscle strips of 3/s, based
on a myosin ATPase activity in skinned human preparations of 50 µM/s at 20 ◦ C [47], a myosin S1
concentration of 157 µM[4], and a Q10 of 3.5 [11].
These differences are potentially related to the swelling of the myofilament lattice as a result of the
skinning process. Such increased distance between thick and thin filaments would be expected to change
the attachment rate and weak-to-strong transition rate of crossbridges. We attempted to prevent the
lattice expansion by using 3% dextran T500 in the solutions. However, in our current experimental setup
this led to very slow flow of solutions through the bath perfusion pipette and preventer proper activation
of the myocytes.
The parameters in the model of tension generation in the skinned myocyte were revised to capture
the distinct changes in tension kinetics observed in intact trabeculae experiments. Which parameters
to change between skinned and intact myocytes is a choice that depends on a balance of physiological
plausibility and effectiveness in reproducing the observed differences. The main kinetic parameters relate
to troponin C, tropomyosin, and crossbridge cycling. Of these, we did not consider the parameters per-
taining to troponin C and tropomyosin, because these are too fast for parameter changes to compensate
for the change in tension kinetics between skinned and intact preparations. Thus, crossbridge rates are a
natural target for consideration. The process of skinning is known to increase inter filament spacing [27],
and this in turn could change the strain on the crossbridge tail. As this could affect both unbound-to-
weak and weak-to-strong binding rates in a unique way, we considered these parameters first. Changing
the distortion decay rates is another potentially effective option. However, as these distortion decay rate
constants are related to crossbridge cycling rates, we considered this the less physiologically plausible to
change these in isolation.
The changes in parameters between the models of isolated skinned myocytes and intact trabeculae
raises serious questions on the underlying cause of these differences. As the experimental data on constant
velocity shortening and quick stretch shows kinetics which are too slow to be compatible with healthy
ejection (Figure 5), the differences between our skinned cell data and isometric twitch kinetics are
unlikely to be a modelling artefact. However, crossbridge cycling rates in models fitted to data from
mouse and rat skinned trabeculae appear to be appropriate for intact whole organ simulations [62, 63].
At present we do not know why the same does not hold with human skinned myocytes and whole-heart
simulations. One possibility is that the attachment of myocytes to the force transducer with adhesive
may introduce some end-compliance, which would slow kinetics, due to internal shortening of sarcomeres.
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This possibility is backed up by the small but consistent overshoot in the sarcomere strain signal (Figure
1), with no overshoot in the length (servomotor) signal, which is consistent with compliance in the
adhesive allowing the sarcomeres in the myocyte to shorten a little after the stretch. Previously we
found no overshoot of SL in similar experiments at 15◦ C [23]. Another possibility is that subtle damage
to sarcomere structure occurs during the standard method for freezing/thawing of the cardiac tissue, or
during subsequent cell isolation procedure. Overall, our initial hypothesis that skinned cardiac myocytes
have crossbridge dynamics consistent with intact cells in whole organ function appears to be incorrect,
at least in the narrow sense of our particular cells and experimental methods. Higher availability of
human myocytes to different research groups, and refinement of techniques used to study their function
at body temperature, would help research in this area. Particularly, the cells used are a scarce resource,
and measurements at body temperature introduce new difficulties in experimental protocol. We have
chosen to generate a range of different experiments to parameterize a simple, but complete computational
model, rather than focus on generating the highest possible sample size for one particular experiment.
As with any complex multi-physics model, our approach has a number of potential limitations. The
cell model does not represent a complete description of all know tension regulatory mechanisms and
its complexity is motivated by the available experimental data. Specifically, feedback from force gen-
eration on Ca2+ affinity for troponin C, while observed experimentally [29], was not included in the
model for three reasons. Firstly, during the tension transient, peak tension occurs during the decay
phase of calcium transient, thus the effect of tension will be limited to the latter phases of the calcium
transient. Secondly, including direct feedback from the S or W states on troponin C calcium affinity
using a simple global feedback term typically leads to hysteresis [57] and has the potential for failure to
relax in a multi-scale modelling setting. Finally, the collected human cardiac experimental data is not
sufficiently detailed to constrain this effect. We model these effects only as a direct length-dependence
of calcium sensitivity, disregarding more complex interactions, to optimize the model in representing
normal physiological function. Our multi-scale model shows slower relaxation of the pressure transient
in isovolumetric relaxation than typically observed in clinical measurements. This is related to the sig-
nificant difference in relaxation time in whole-organ experimental data as compared to isometric twitch
data. A potential solution which was recently proposed [7] involves the modelling of internal shortening,
which may extend the duration of tension generation, and improve subsequent relaxation. However,
this modelling approach is currently not adapted to an ODE based framework and requires additional
parameters for the hypothetical mechanism. Our model does not include beta-adrenergic stimulation,
which may create disparities between cellular and whole-organ conditions, although these are expected
to be relatively small under basal conditions.
In conclusion, we have presented a comprehensive new data set on contractile function in human
cardiomyocytes at body temperature. The computational model developed from this data set can be
used to drive a range of new computational research into human cardiac function. Model equations,
parameters, and UNIPROT codes corresponding to model proteins are provided in the appendix 2.
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A Model equations
The model of passive and viscoelastic tension development consists of a single ordinary differential
equation:
dC
dt
=
dλ
dt
− 1 (40)
F1 = a(e
bC − 1) (parallel elastic element) (41)
F2 = akCs (series elastic element) (42)
Fd =
{
aηl
dCd
dt
dCd
dt > 0
aηs
dCd
dt
dCd
dt < 0
(viscous dashpot element) (43)
Cs + Cd = C (series constraint) (44)
F2 = Fd (series constraint) (45)
Ftot = F1 + F2 = F1 + Fd (total tension) (46)
The model of active tension development consists of six ordinary differential equations:
dCaTRPN
dt
= kTRPN
((
[Ca2+]i
[Ca2+]T50
)nTRPN
(1− CaTRPN)− CaTRPN
)
(47)
dB
dt
= kb · CaTRPN−nTm/2 · U − ku · CaTRPNnTm/2 ·B (48)
dW
dt
= kuwU − kwuW − kwsW − γwuW (49)
dS
dt
= kwsW − ksuS − γsuS (50)
dζw
dt
= Aw
dλ
dt
− cwζw (51)
dζs
dt
= As
dλ
dt
− csζs (52)
Ta =
Tref
rs
(S(ζs + 1) +Wζw) (53)
Where:
λ = SL/SL0 = ‖Ff‖ (in multiscale simulations) (54)
U = (1−B)− S −W (55)
γwu = γw|ζw| (56)
γsu =
 γs(−ζs − 1) if ζs + 1 < 0γsζs if ζs + 1 > 1
0 otherwise (if ζs + 1 ∈ [0, 1])
(57)
As = Aw = Aeff · rs/((1− rs)rw + rs) (58)
kwu = kuw(1/rw − 1)− kws (59)
ksu = kwsrw(1/rs − 1) (60)
kb = kuCaTRPN
nTm/(1− rs − (1− rs)rw) (61)
cw = φ · kuw · U/W = φ · kuw · ((1− rs)(1− rw))/((1− rs)rw) (62)
cs = φ · kws ·W/S = φ · kws · ((1− rs)rw)/rs (63)
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In the context of an isolated myocyte, total tension is given by:
Ta + Ftot (64)
In a multi-scale modelling application, only part of the viscoelastic force in the model should be
included, resulting in:
Ta + Fd (65)
B Model parameters
Model parameters are given by:
Parameter Skinned model value Whole organ model value (if different)
Passive tension model
a 2.1 kPa
b 9.1
k 7
ηl 200/ms
ηs 20/ms
Active tension model
kTRPN 0.1/ms
nTRPN 2
[Ca2+]refT50 2.5 µM 0.805 µM
ku 1/ms
nTm 2.2 5
TRPN50 0.35
kuw 0.026/ms 0.182/ms
kws 0.004/ms 0.012/ms
rw 0.5
rs 0.25
γs 0.0085
γw 0.615
φ 2.23
Aeff 25
β0 2.3
β1 -2.4
Tref 40.5 kPa 120 kPa
C Cost functions used in fitting
C.1 Velocity dependence
Simulations for constant velocity shortening are faster, but also constrain fewer of the parameters,
while simulations with the quick stretch protocol contain more information about crossbridge kinet-
ics. We fit the velocity dependence model by doing a parameter sweep on the constant shortening
experiments using a very simple cost function, thoroughly exploring the parameter space in an ef-
ficient manner, but not fully constraining the model. We start by fitting the cost function ds =
50 (‖Fs(10%, 100)− 0.2‖+ ‖Fs(10%, 200)− 0.4‖+ ‖Fs(10%, 300)− 0.5‖), where Fs(δ, te) is the fraction
of active tension remaining after shortening by δ in te ms. This cost function corresponds to matching
the center of the experimental data for shortening in 100, 200, 300 ms The ranges of the parameter sweep
were set to kws ∈ [0.001, 0.05], kuw ∈ [0.02, 1], φ ∈ [0.1, 4], γs ∈ [0.005, 0.02], γw ∈ [0.05, 3] based on earlier
parameters fitted to pilot data. We also tested alternative rw ∈ [0.25, 0.75], rs ∈ [0.1, 0.25]. Of the 46656
parameter sets tested, the minimal ds score was 8.6. We included the 2526 parameter sets with cost
ds < 17 in the fitting procedure for quick stretch experiments, all of which had rw = 0.5, rs = 0.25.
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Other than φ > 0.2, no hard constraints on the other parameters were found, showing that constant
velocity shortening experiments in isolation do not sufficiently constrain our model parameters.
To further constrain the distortion-decay component of the model, we compared model predictions
with quick stretch experimental data. To fit our distortion-decay component to the quick stretch data,
our full computational model is run to steady-state to generate the steady-state initial condition, using
[Ca2+]i = 30µM, λ = 1 consistent with the experimental protocol. Experimental data for velocity
dependence, like those in the previous section, again show high variability in tension development. As
all parameters fitted in this section relate to the relative effects of distortion on force development, we
compensate for this variability by normalizing all experimental data and model runs to be relative to
tension development at the start of the protocol. Small differences remain in force at the start and end of
the experimental protocol, which we assume are due to lack of complete steady-state at the start of the
protocol. We choose our initial model condition by picking a time point from the steady-state calculation
which matches this relative force development, and allows the model to fit both of these points exactly.
As we wish to focus on distortion-decay kinetics in this data, as opposed to force-length interactions, we
correct for differences in length dependence by adjusting β0 for each of the three simulations, such that
the change in tension between steady-state with the change in length is exactly captured by the length
dependence equation. We define a cost function dv =
∫ ‖Ta(t) − Fe(t)‖2 between the model force and
the average experimental traces. The model force includes the generation of passive force, although it
contributes less than 10% to the response to a quick stretch at this level of activation. Similar to the
passive tension model fitting, we start by fitting Aeff = 25 to the instantaneous response in force after
a quick change in length. This response is limited to a narrow region in time, and is therefore not well
constrained by our cost function. Next, we test all 2526 selected parameter sets from our parameter sweep
on the constant velocity shortening data described above The dv score for these varies between 107 and
2973, showing that including the quick stretch experiments is key in constraining parameters. We select
the parameter set with minimal dv and use this as a starting point for the Nelder-Mead minimization
algorithm with the cost function dv + ds.
C.2 Isometric twitch
Our target ranges for isometric twitch are given by a time to peak tension (TPT) of 147–172 ms, a time
to 50% relaxation (RT50) of 109–125 ms and a time to 95% relaxation (RT95) of 291–377 ms. Based on
these measurements, we use the cost function:
dt = d(TPT, [147, 172])+d(RT50, [109, 125])+d(RT95, [291, 377])+10d(maxF, [50,∞))+25 minF (66)
Where F (t) is the twitch force over time, and d(a, [b, c]) is the distance from a to the range [b, c], i.e. zero if
a ∈ [b, c] and the minimal absolute distance to b or c otherwise. Weights for minimal and maximal active
tension were chosen to ensure good activation and relaxation as a first priority, which are particularly
important for use of the cellular model to drive whole organ contraction. Maximal active tension Tref
is not constrained by this data and was set to 120 kPa, consistent with force required for whole organ
contraction in previous work [37] and recent data [7].
In addition to the calcium sensitivity [Ca2+]refT50 and Hill coefficient nTm, the tropomyosin rate constant
ku is yet to be determined. In fitting, we use a three-dimensional parameter sweep over the ranges
[Ca2+]refT50 ∈ [0.8, 0.9], nTm ∈ [3, 7], ku ∈ [0.01, 2] to determine the parameters. Within these constraints,
no suitable parameters were found, with the minimal dt = 462. We introduced a factor µ ∈ [1, 12], which
scales the weak-to-strong crossbridge transition rate kws, and νin[1, 12], which scales the unbound-to-
weak transition rate kuw. Fitting using this parameter sweep approach results in a minimum dt = 8,
near the constraints for relaxation and activation kinetics.
D Raw data for force-velocity experiments
Figure 8 shows the experimental data for the constant velocity shortening experiments.
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Figure 8: Experimental data for constant velocity shortening experiments. Shown in this figure
is the raw data relating to Figure 5B.
E UNIPROT Codes
Equations in the model are linked to contractile proteins in a human cardiac myocyte. The table below
gives the corresponding UNIPROT codes for these proteins.
Model variable Related protein UNIPROT code
CaTRPN troponin C P63316
B tropomyosin P09493
B troponin I P19429
B actin P68032
W,S, ζw, ζs myosin II heavy chain Q9UKX2
W,S, ζw, ζs myosin II light chain P10916
passive model titin (among others) Q8WZ42
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